NCT00439894已完成不适用
Protein Phosphorylation Ancillary Study to Amgen Protocol 20060104: Open Label Study to Assess the Safety and Immunogenicity of Etanercept SFP When Administered to Subjects Diagnosed With Rheumatoid Arthritis
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- Amgen
- 入组人数
- 50
- 主要终点
- To explore the correlation between pheripheral blood cell protein phosphorylation assessemnts and rheumatoid arthritis disease activity.
研究概览
简要总结
Ancillary study to the Etanercept protocol 20060104. Subjects have been asked to provide additional blood samples for further assessment.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Signed informed Consent Meet all inclusion critieria outlined in Amgen Protocol 20060104
排除标准
- •Meet exclusion criteria outlined in Amgen Protocol 20060104
结局指标
主要结局
To explore the correlation between pheripheral blood cell protein phosphorylation assessemnts and rheumatoid arthritis disease activity.
时间窗: week 24
次要结局
- Explore the correlations to etanercept clinical response (ACR and DAS scores) may also be explored.(week 24)
研究者
相似试验
终止
2 期
Study of Parathyroid Hormone Following Sequential Cord Blood Transplantation From an Unrelated DonorLeukemia, Myeloid, ChronicAnemia, AplasticHodgkin DiseaseLymphomaLeukemia, Lymphocytic, ChronicLeukemia, Myelocytic, AcuteLeukemia, Lymphocytic, AcuteMyelofibrosisNCT00393380The Emmes Company, LLC13
Unknown
3 期
ADD-ON Study to Existing Hypoparathyroidism StudiesHypoparathyroidismNCT00856401National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)62
已完成
1 期
Antidepressant Effects on cAMP Specific Phosphodiesterase (PDE4) in Depressed PatientsHealthyMajor Depressive DisorderNCT00369798National Institute of Mental Health (NIMH)100
招募中
不适用
A study on organ protection during bypass sugery by inflating a bloodpressure cuff on the arm.CABG, remote preconditioning, cardioprotectionNL-OMON21859Academical Medical Centre, University of Amsterdam56
已完成
1 期
A Clinical Study to Investigate the Effect of an Investigational Drug as an Added Medication to an Antipsychotic, in Adults With Schizophrenia, as Measured Positron Emission Tomography (PET) ImagingSchizophreniaNCT04038957Otsuka Pharmaceutical Development & Commercialization, Inc.22